Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations
Condition(s) studied
Investigational drug(s) / intervention(s)
Adrenalectomy: Adrenalectomy according to 2016 ESE guidelines
Study summary
The investigators hypothesize that cardiovascular and metabolic alterations can occur in patients with adrenal adenomas and possible Autonomous Cortisol Secretion (pACS). Investigators hypothesize that adrenalectomy in selected patients, following the 2016 European Congress of Endocrinology (ECE) guidelines, can improve metabolic parameters and cardiovascular risks and features.
Eligibility
Primary outcome measure(s)
- Echocardiographic Change of Left Ventricular Hypertrophy — at Baseline (T0) and after 1 year (t1) and 5 years (t2)
Change of Left Ventricular Hypertrophy will be evaluated by transthoracic echocardiography. Patients will be examined in the left lateral decubitus position according to the American Society of Echocardiography guidelines.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Experimental Medicine | Rome | Italy | Recruiting |
More University of Roma La Sapienza trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04127552 on ClinicalTrials.gov ↗ ← All trials in Italy